Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase II Study of MLN8237 in Advanced/Metastatic Sarcoma

NCT01653028 is registered in ClinicalTrials.gov with National Cancer Institute (NCI) as lead sponsor.

NCT NCT01653028
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01653028 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase II Study of MLN8237 in Advanced/Metastatic Sarcoma
Lead sponsor
National Cancer Institute (NCI)
Phase
Phase 2
Overall status
Completed
Start date
August 22, 2012
Completion date
Not reported
Enrollment
72 (actual)
Sites
235

Conditions

As the registry lists them; a condition with its own page is linked.

myxofibrosarcoma, recurrent adult soft tissue sarcoma, recurrent leiomyosarcoma, recurrent liposarcoma, recurrent malignant peripheral nerve sheath tumor, recurrent undifferentiated pleomorphic sarcoma, stage iii soft tissue sarcoma ajcc v7, stage iv soft tissue sarcoma ajcc v7